Details for New Drug Application (NDA): 012594
✉ Email this page to a colleague
NDA 012594 describes METAHYDRIN, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the METAHYDRIN profile page.
The generic ingredient in METAHYDRIN is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
The generic ingredient in METAHYDRIN is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
Summary for 012594
| Tradename: | METAHYDRIN |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | trichlormethiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012594
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jun 16, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | Jun 16, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
